Recent Updates
Recently added Catalysts
KIDS Positive Sentiment Score: 85/100

OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches

Key Takeaway: OrthoPediatrics Corp. has expanded its Specialty Bracing portfolio with the launch of two new products, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems. These products are designed for treating Developmental Dysplasia of the Hip (DDH) in children aged three years and younger. The new additions bring the total to 31 systems in the OPSB division, enhancing treatment options for pediatric patients.

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of two new products enhances treatment options.
  • Collaboration with pediatric hip experts ensures quality.
  • Strengthening of the OPSB portfolio demonstrates commitment to pediatric care.

Full Press Release Details

WARSAW, Ind., Nov. 13, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing (“OPSB”) portfolio with two new products launches, the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems. The company now has 31 systems within its OPSB division.
Developed in collaboration with globally recognized pediatric hip experts, the PediHip™ Rigid Brace and PediHip™ Modular Abduction System are intended for the treatment of Developmental Dysplasia of the Hip (DDH) and post-operative stabilization in pediatric patients ages three years and younger. These two new products will greatly enhance the current options to treat this condition, ultimately benefiting the patient and parent.
Joe Hauser, OrthoPediatrics Specialty Bracing division President, commented, “We have been focused on organic new product development and are thrilled to announce these two new launches as we continue to strengthen our OPSB portfolio. The PediHip™ portfolio showcases our commitment to partnering with providers to advance care for children. In combination with the Trauma & Deformity portfolio, including the newly launched 3P Hip System, OrthoPediatrics can now provide treatment solutions for the entire pediatric hip care continuum.”

About OrthoPediatrics Corp.

Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 85 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visitwww.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visitwww.opsb.com.

Investor ContactPhilip Trip TaylorGilmartin Groupphilip@gilmartinir.com415-937-5406

Frequently Asked Questions

What are the new products launched by OrthoPediatrics?

OrthoPediatrics launched the PediHip™ Rigid Brace and PediHip™ Modular Abduction Systems.

What conditions do the new products treat?

The new products are intended for treating Developmental Dysplasia of the Hip (DDH).

What age group is targeted by these new products?

These products are designed for pediatric patients aged three years and younger.

How many systems are now in the OPSB division?

The OPSB division now includes a total of 31 systems.

Last updated: Nov 13, 2025